title: Ulcerative colitis associated with interferon treatment for chronic hepatitis C.
authors.forename: C
authors.initials: C
authors.lastname: Mavrogiannis
authors.forename: I S
authors.initials: IS
authors.lastname: Papanikolaou
authors.forename: I S
authors.initials: IS
authors.lastname: Elefsiniotis
authors.forename: D I
authors.initials: DI
authors.lastname: Psilopoulos
authors.forename: A
authors.initials: A
authors.lastname: Karameris
authors.forename: G
authors.initials: G
authors.lastname: Karvountzis
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D019804:Mesalamine / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011994:Recombinant Proteins
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019804:Mesalamine; D011241:Prednisone